1

Amyris

Amyris
Leadership team

Mr. John G. Melo (Pres, CEO & Director)

Mr. Hermanus Kieftenbeld (CFO & Chief Admin. Officer)

Mr. Eduardo Alvarez (Chief Operating Officer)

Products/ Services
Biotechnology, Chemical, CleanTech, Renewable Energy
Number of Employees
500 - 1000
Headquarters
Emeryville, California, United States
Established
2003
Company Registration
SEC CIK number: 0001365916
Revenue
100M - 500M
Traded as
AMRS
Social Media
Overview
Location
Summary
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.
History

Amyris was founded in 2003. The company owns three brands, Biossance and Pipette, for beauty and skincare, and Purecane, a sugar substitute. The company went public on NASDAQ on September 28, 2010 .In November 2011, Amyris acquired Lansing, Michigan-based renewable chemicals and products company, Draths Corporation, for $7 million in stock. April 2019, the company raised $34-million in private placement of its common stock and warrants. The funding round was led by Foris Ventures and Dr. Wei-wu He, General Partner of Emerging Technology Partners, LLC, a life sciences-focused venture fund.In 2020, Amyris received Bonsucro's Chain of Custody Certification, ensuring that the sustainability claims along the sugarcane supply chain are traceable from farmer to end user. During the COVID-19 pandemic, the company collaborated with the Infectious Disease Research Institute to advance a novel ribonucleic acid vaccine platform, including accelerating the development of a COVID-19 vaccine.

Mission
To solve global problems with innovative solutions that are both renewable and sustainable – real solutions that don’t compromise on performance, affordability or availability.
Vision
To make the best products available to all and to help humanity while we do it.
Key Team

Ms. Nicole Kelsey (Chief Legal Officer & Sec.)

Ms. Elizabeth E. Dreyer CPA (Chief Accounting Officer & Corp. Controller)

Mr. Peter DeNardo (Sr. Director of Investor Relations & Corp. Communications)

Ms. Christine Ofori (Chief People Officer)

Mr. Charles Kraft (Sr. VP of Global Manufacturing & Process Devel.)

Ms. Caroline Hadfield (Pres of Aprinnova)

Mr. Jim Iacoponi (Sr. VP of Nutrition Ingredients)

Recognition and Awards
Amyris has won several awards, including a Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection Agency, an R&D 100 Award from the editors of R&D Magazine, and a Best of What’s New Award from Popular Science magazine.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Amyris
Leadership team

Mr. John G. Melo (Pres, CEO & Director)

Mr. Hermanus Kieftenbeld (CFO & Chief Admin. Officer)

Mr. Eduardo Alvarez (Chief Operating Officer)

Products/ Services
Biotechnology, Chemical, CleanTech, Renewable Energy
Number of Employees
500 - 1000
Headquarters
Emeryville, California, United States
Established
2003
Company Registration
SEC CIK number: 0001365916
Revenue
100M - 500M
Traded as
AMRS
Social Media